Equities

Santen Pharmaceutical Co Ltd

Santen Pharmaceutical Co Ltd

Actions
  • Price (EUR)10.80
  • Today's Change-0.10 / -0.92%
  • Shares traded29.00
  • 1 Year change+22.73%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 07:06 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income26,703(14983)27,189
Depreciation/depletion18,17817,24917,055
Non-Cash items15,74347,5778,253
Cash taxes paid, supplemental12,1087,81810,246
Cash interest paid, supplemental830465240
Changes in working capital12,025(12696)(6454)
Total cash from operations72,64937,14746,043
INVESTING
Capital expenditures(10687)(24588)(35841)
Other investing and cash flow items, total4,542(2189)672
Total cash from investing(6145)(26777)(35169)
FINANCING
Financing cash flow items217445147
Total cash dividends paid(11881)(12607)(11994)
Issuance (retirement) of stock, net(16962)(26007)--
Issuance (retirement) of debt, net(5405)94917,404
Total cash from financing(34031)(37220)5,557
NET CHANGE IN CASH
Foreign exchange effects4,2061,7393,694
Net change in cash36,679(25111)20,125
Net cash-begin balance/reserved for future use57,90383,01462,888
Net cash-end balance/reserved for future use94,58257,90383,014
SUPPLEMENTAL INCOME
Depreciation, supplemental18,17817,24917,055
Cash interest paid, supplemental830465240
Cash taxes paid, supplemental12,1087,81810,246
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.